Načítá se...
Combination of Paclitaxel and MG1 oncolytic virus as a successful strategy for breast cancer treatment
BACKGROUND: Breast cancer is the most common malignant disease amongst Western women. The lack of treatment options for patients with chemotherapy-resistant or recurrent cancers is pushing the field toward the rapid development of novel therapies. The use of oncolytic viruses is a promising approach...
Uloženo v:
| Vydáno v: | Breast Cancer Res |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4977613/ https://ncbi.nlm.nih.gov/pubmed/27503504 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-016-0744-y |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|